With the overwhelming and ongoing number of job losses across the pharmaceutical industry, few would be surprised that many employees are anxious about the future. Each drugmaker has slashed research projects and marketing budgets, sending scientists and sales reps overboard at eye-popping rates. Also high on the list: the people who get the drugs out the door, thanks to plant closures.
